Leone D. Patterson - 19 May 2022 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Reporting relationship: Director
Issuer ticker: CLYM
Reported as of: 19 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2022, 17:12:18 UTC
Prior SEC filing: 17 Feb 2022
Next SEC filing: 10 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian Woodard, Attorney-in-Fact

Key filing fact

Leone D. Patterson filed Form 4 for Eliem Therapeutics, Inc. (CLYM) on 01 Jun 2022.

Key facts

This page summarizes Leone D. Patterson's Form 4 filing for Eliem Therapeutics, Inc. (CLYM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jun 2022, 17:12.

Change

Previous filing in this sequence was filed on 17 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELYM transaction Derivative

Stock Option (Right To Buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 19 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.46
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest on the earlier of May 19, 2023 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.